P M Martikainen
Overview
Explore the profile of P M Martikainen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
281
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maki H, Saramaki O, Shatkina L, Martikainen P, Tammela T, van Weerden W, et al.
J Pathol
. 2007 May;
212(4):395-401.
PMID: 17503439
BAG-1L (Bcl-2-associated anthanogene 1) has been found to interact with androgen receptor (AR), and has been suggested to be involved in the development of prostate cancer. In order to determine...
2.
Soini Y, Kallio J, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Kang S, et al.
APMIS
. 2006 May;
114(5):329-37.
PMID: 16725008
Peroxiredoxins (Prxs) 1-6 were assessed in 138 renal cell carcinomas (RCC) using immunohistochemistry and selected samples by Western blotting analysis. Oxidative/nitrosative damage was evaluated using nitrotyrosine immunoreactivity. The expressions of...
3.
Perttu M, Martikainen P, Huhtala H, Blauer M, Tammela T, Tuohimaa P, et al.
Prostate Cancer Prostatic Dis
. 2006 Mar;
9(2):185-9.
PMID: 16550207
Alterations have been demonstrated in ligand and cognate receptor system of the transforming growth factor beta (TGF-beta) pathway in prostate cancer (PC). Still, little is known about changes in the...
4.
Soini Y, Kallio J, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Tammela T, et al.
Histol Histopathol
. 2005 Dec;
21(2):157-65.
PMID: 16329040
The aim of the study was to estimate the significance of oxidative/nitrosative damage and expression of antioxidant enzymes in renal cell carcinomas (RCC). For this we investigated immunohistochemically six antioxidant...
5.
Blauer M, Heinonen P, Martikainen P, Tomas E, Ylikomi T
Hum Reprod
. 2005 Jan;
20(4):864-71.
PMID: 15665014
Background: A novel organotypic culture system was established for modelling the hormonal responses of the normal human endometrium in vitro. Methods: Endometrial epithelial cells were cultured as glandular organoids within...
6.
van der Kwast T, Roobol M, Wildhagen M, Martikainen P, Maatanen L, Pihl C, et al.
BJU Int
. 2004 Feb;
92 Suppl 2:88-91.
PMID: 14986593
Objective: To assess the consistency of grading outcome among seven of eight participating centres of the European Randomised Screening Program of Prostate Cancer (ERSPC), a multicentre randomized trial intended to...
7.
van der Kwast T, Lopes C, Martikainen P, Pihl C, Santonja C, Neetens I, et al.
BJU Int
. 2004 Feb;
92 Suppl 2:62-5.
PMID: 14983958
No abstract available.
8.
Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma
Kallio J, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Luukkaala T, Tammela T, et al.
Br J Cancer
. 2003 Oct;
89(7):1266-9.
PMID: 14520458
Epidermal growth factor receptor (EGFR) is a key factor in tumorigenesis. The association between EGFR expression and prognosis in renal cell carcinoma (RCC) is not clear. In our study of...
9.
Valve E, Nevalainen M, Nurmi M, Laato M, Martikainen P, Harkonen P
Lab Invest
. 2001 Jun;
81(6):815-26.
PMID: 11406643
Fibroblast growth factor 8 (FGF-8) is implicated in growth of prostate cancer. Alternative splicing of the human FGF-8 gene potentially allows coding for four protein isoforms (a, b, e, and...
10.
Ahonen T, Harkonen P, Laine J, Rui H, Martikainen P, Nevalainen M
Endocrinology
. 1999 Oct;
140(11):5412-21.
PMID: 10537173
PRL is one of several polypeptide factors that regulate growth and differentiation of prostate epithelium besides steroid hormones. This hormone may also participate in the development of pathologic changes of...